tiprankstipranks
ZyVersa Therapeutics (ZVSA)
NASDAQ:ZVSA
US Market

ZyVersa Therapeutics (ZVSA) Financial Statements

111 Followers

ZyVersa Therapeutics Financial Overview

ZyVersa Therapeutics's market cap is currently ―. The company's EPS TTM is $-1896.093; its P/E ratio is >-0.01; ZyVersa Therapeutics is scheduled to report earnings on August 19, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -23.12M$ -2.90M$ -86.33M$ 4.59M$ 925.11K
EBITDA$ -23.12M$ -2.90M$ -86.32M$ 4.59M$ 925.64K
Net Income Common Stockholders$ -22.52M$ -2.93M$ -86.43M$ 5.64M$ 2.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.14M$ 1.58M$ 228.69K$ 1.28M$ 5.90M
Total Assets$ 22.11M$ 32.85M$ 31.99M$ 114.66M$ 118.51M
Total Debt$ 8.66K$ 34.35K$ 59.63K$ 84.51K$ 108.76K
Net Debt$ -3.13M$ -1.54M$ -169.07K$ -1.19M$ -5.79M
Total Liabilities$ 11.04M$ 13.15M$ 11.93M$ 17.90M$ 18.51M
Stockholders Equity$ 11.07M$ 19.70M$ 20.06M$ 97.10M$ 99.68M
Cash Flow-
Free Cash Flow$ -2.79M$ -936.39K$ -407.62K$ -4.59M$ -2.68M
Operating Cash Flow$ -2.79M$ -936.39K$ -407.62K$ -4.59M$ -2.68M
Investing Cash Flow----$ 2.70M
Financing Cash Flow$ 4.35M$ 2.29M$ -641.76K$ -34.67K$ -832.92K
Currency in USD

ZyVersa Therapeutics Earnings and Revenue History

ZyVersa Therapeutics Debt to Assets

ZyVersa Therapeutics Cash Flow

ZyVersa Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis